Intuitive Surgical beats analyst estimates with strong revenue growth and profitability

From StockStory: 2025-01-31 15:02:39

Intuitive Surgical (NASDAQ: ISRG) reported Q4 CY2024 revenue of $2.41 billion, beating analyst estimates by 6.5% with a 25.2% year-on-year growth. The company’s non-GAAP profit of $2.21 per share exceeded consensus estimates by 23.8%. Intuitive Surgical is known for its da Vinci robotic surgical systems and has a market capitalization of $206.6 billion. The company has demonstrated solid sales growth, with a 13.3% compounded annual growth rate over the last five years and an annualized revenue growth of 15.9% over the last two years. Adjusted operating margin for the quarter was 38.4%, up 6.2 percentage points year on year. In Q4, Intuitive Surgical reported an EPS of $2.21, beating estimates and showing a year-on-year increase from $1.60. Wall Street expects full-year EPS of $7.33 to grow by 7.5% over the next 12 months.

The surgical equipment and consumables industry benefits from consistent demand for tools, devices, and disposable products used in medical procedures. Intuitive Surgical’s strong revenue growth and profitability demonstrate its efficiency and performance in the healthcare sector. The company’s ability to innovate and meet customer demand has contributed to its success in the market. With the integration of AI and robotics in surgical procedures, there are opportunities for differentiation and growth within the industry. Overall, Intuitive Surgical’s Q4 results showcase positive performance and potential for future success.



Read more at StockStory: Intuitive Surgical (NASDAQ:ISRG) Delivers Impressive Q4